Silencing of SOCS5 by its siRNA abrogated the effect of leonurine on CML cells, demonstrating that SOCS5 mediates the anti-leukemia effect of leonurine. The gene discussed is SOCS5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.